According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...

On February 4, Merck released financial ... especially given the significant investments the Rahway, New Jersey-based company has made in developing its oncology franchise over the past year ...

Merck (NYSE:MRK) is preparing to launch a subcutaneously delivered formulation of their blockbuster cancer medication ... accounts for the bulk of the Rahway, New Jersey-based pharmaceutical ...

With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK ... and a variety of treatments in oncology, immunology, and infectious diseases, as well as its commitment ...